Alan Laboratories Inc. is a newly established specialty contract research organization in San Diego. The company focuses on the development of sustained-release, extended-release and delayed-release solid dose formulation technologies. We provide analytical, pre-formulation and formulation services to pharmaceutical and biotechnology companies to develop hard-to-formulate or controlled-release products. Leveraging its unique formulation technologies, Alan Laboratories Inc. has established long-term collaborations with multiple pharmaceutical companies since 2013. The company also applies its own technologies to develop improved formulations of existing drugs that can be categorized as 505(b)(2) NDA candidates.